✨
AI Summary
- Rachel Haurwitz on Caribou Biosciences' off-the-shelf CRISPR CAR-T therapies.
- Discusses Vispacell for second-line large B-cell lymphoma treatment.
- Explains systematic optimization of allogeneic cell therapies.